The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Surviving Cancer CAMPetently: Evidence-based Care Delivered at Family Camp |
Nemours A.I. duPont Hospital for Children / Melissa Alderfer, PhD |
Psychosocial Family Impact Grant |
2018 |
Delaware |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research / Andrew Napper |
Innovation Grants |
2010 |
Delaware |
Screen to Intervene: A Family-Centered Approach to Identifying and Communicating Family Psychosocial Risk and Developing Evidence Based Clinical Pathways in Hematopoietic Stem Cell Transplantation |
Alfred I duPont Hospital for Children / Anne Kazak, PhD |
Psychosocial Grants |
2015 |
Delaware |
Inhibition of Cathepsins to Treat Neuroblastoma |
Alfred I duPont Hospital for Children / Robert Mason |
Innovation Grants |
2008 |
Delaware |
Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma |
Georgetown University / Todd Waldman, MD, PhD |
Innovation Grants |
2015 |
District of Columbia |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Child and Adolescent Preferences for Involvement in their Cancer Treatment Decisions |
Children’s Research Institute / Katherine Kelly, Ph.D. |
Nurse Researcher Grants |
2012 |
District of Columbia |
Developing an accurate genetic model for rhabdomyosarcoma therapy
|
Children’s Research Institute / Dawn Chandler, PhD |
Young Investigator Grants |
2007 |
District of Columbia |
An Engineered Nanoimmunotherapy for Treating Neuroblastoma |
George Washington University / Rohan Fernandes, PhD |
'A' Award Grants |
2016 |
District of Columbia |